• Price (EUR)34.80
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change42.04%
  • Beta0.8862
Data delayed at least 15 minutes, as of Oct 23 2020 08:57 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

As of last trade, Chugai Pharmaceutical Co Ltd (CUP:FRA) traded at 34.80, 42.04% above the 52 week low of 24.50 set on Oct 28, 2019.
52-week range
24.50Oct 28 201951.67Jun 26 2020
Markit short selling activity
Previous close34.80
Average volume165.90
Shares outstanding1.68bn
Free float668.73m
P/E (TTM)34.76
Market cap7.19tn JPY
EPS (TTM)123.16
Annual div (ADY)0.4604
Annual div yield (ADY)1.32%
Div ex-dateJun 29 2020
Div pay-dateAug 28 2020
Next div ex-dateDec 29 2020
Next div pay-date--
Data delayed at least 15 minutes, as of Oct 23 2020 08:57 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.